Effects of Tuberculosis, Race, and Human Gene <i>SLCO1B1</i> Polymorphisms on Rifampin Concentrations
Marc Weiner(The University of Texas at San Antonio Health Science Center), Andrew Vernon(Centers for Disease Control and Prevention), John L. Johnson(University of Pennsylvania), Charles A. Peloquin(University of Florida), Chi-Cheng Luo(Centers for Disease Control and Prevention), Erin Bliven-Sizemore(Centers for Disease Control and Prevention), William R. Mac Kenzie(Georgia Department of Public Health), Melissa Engle(The University of Texas at San Antonio Health Science Center), Thomas J. Prihoda(The University of Texas at San Antonio Health Science Center), William J. Burman(Case Western Reserve University)
Cited by 156
Related Papers
Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis
|Clinical Infectious Diseases|2016|1.5k
Updated guidelines for using Interferon Gamma Release Assays to detect Mycobacterium tuberculosis infection - United States, 2010.
|PubMed|2010|1.1k
Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses
|Immunity|2021|713